The management of urinary function relies on a delicate balance between the parasympathetic and sympathetic nervous systems. When the bladder fails to empty (urinary retention) or contracts too frequently (overactive bladder/incontinence), pharmacological intervention can either stimulate or inhibit specific muscarinic or adrenergic receptors to restore normal function. Understanding the nuances of receptor selectivity, metabolic pathways, and side-effect profiles is essential for clinical practice.
Physiology of Bladder Control
To understand these medications, one must first understand the receptors involved in micturition. The parasympathetic nervous system (PNS) promotes voiding, while the sympathetic nervous system (SNS) promotes retention.
The primary driver of bladder contraction is the muscarinic receptor located on the detrusor muscle. When receptors are activated, the detrusor muscle contracts, increasing bladder pressure to allow for urination. Conversely, the sympathetic nervous system utilizes receptors to maintain contraction of the trigone and urethral sphincters, which promotes urinary retention.
Cholinergic Agents: Treating Urinary Retention
When a patient suffers from urinary retention—often due to neurogenic bladder or post-operative/post-partum complications—the goal is to stimulate the bladder to contract.
Bethanechol
Bethanechol is a direct-acting muscarinic agonist that is selective for , , and receptors. By stimulating the receptors on the detrusor muscle, it increases voiding pressure while simultaneously promoting the relaxation of the trigone and sphincter muscles.
Clinical Considerations:
- Administration: It is typically taken orally (PO) 1 hour before meals or 2 hours after meals to minimize gastrointestinal side effects like nausea and vomiting.
- Adverse Effects: Because it stimulates the parasympathetic system, it can cause "cholinergic" effects, including increased salivation, sweating, abdominal cramps, diarrhea, and even bronchoconstriction. It may also cause a decrease in blood pressure (BP) and heart rate (HR).
- Contraindications: It should be avoided in patients with physical obstructions, hypotension, or active asthma.
Keep reading for free.
Create an account to finish this reading and make it part of your study routine.
Continue reading freeAlready have an account? Log in
Updated